# Benapenem PK Phase Ib Multiple-dose Study

> **NCT03578588** · PHASE1 · COMPLETED · sponsor: **Sihuan Pharmaceutical Holdings Group Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Health, Subjective

## Interventions

- **DRUG:** Banapenem

## Key facts

- **NCT ID:** NCT03578588
- **Lead sponsor:** Sihuan Pharmaceutical Holdings Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-14
- **Primary completion:** 2016-01-13
- **Final completion:** 2016-01-13
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03578588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03578588, "Benapenem PK Phase Ib Multiple-dose Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03578588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*